Disease Synopsis
Overview
Drugs and Clinical Candidates
Clinical Trials (visual)
Clinical Trials (text)
Cell Line Models
Chemistry

Neuroblastoma - Overview - Disease Synopsis

Drugs & Clinical Candidates


5 drugs have received FDA approval for Neuroblastoma . BuMel, Cyclophosphamide, Dinutuximab, Doxorubicin Hydrochloride and Vincristine Sulfate
147 drugs have a clinical trial registered for Neuroblastoma.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Clinical Trials


There are 450 clinical trials for Neuroblastoma,
316 of which have one or more drug interventions,
134 with no drug intervention.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Cell Line Models


There are 288 Cell Line Models for Neuroblastoma.

Source: COSMIC
(see details)

Chemistry


There are 781 Compounds which have been tested in Neuroblastoma , 547 <= 500nM potency.

Source: ChEMBL
(see details)

Mappings


Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Neuroblastoma:
Esthesioneuroblastoma, Olfactory
Ganglioneuroblastoma
Neuroblastoma

The following terms have been mapped from cancer.gov to Neuroblastoma:
Neuroblastoma
Neuroblastoma that is high risk. It is used in children who had at least a partial response to other drugs and other types of treatment
Neuroblastoma that is high risk. It is used to prepare patients for a stem cell transplant